Daniel P. Gold Ph.D., Chief Executive Officer at MEI Pharma, Inc. (MEIP), bought 18,750 shares at $1.60 ($30K) on 2019-12-19, disclosed to the SEC on 2019-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.